Altered lipid composition in Streptococcus pneumoniae cpoA mutants by Marina Meiers et al.
Meiers et al. BMC Microbiology 2014, 14:12
http://www.biomedcentral.com/1471-2180/14/12RESEARCH ARTICLE Open AccessAltered lipid composition in Streptococcus
pneumoniae cpoA mutants
Marina Meiers1†, Carsten Volz1,2†, Jessica Eisel1, Patrick Maurer3, Bernhard Henrich1 and Regine Hakenbeck1*Abstract
Background: Penicillin-resistance in Streptococcus pneumoniae is mainly due to alterations in genes encoding
the target enzymes for beta-lactams, the penicillin-binding proteins (PBPs). However, non-PBP genes are altered
in beta-lactam-resistant laboratory mutants and confer decreased susceptibility to beta-lactam antibiotics. Two
piperacillin resistant laboratory mutants of Streptococcus pneumoniae R6 contain mutations in the putative
glycosyltransferase gene cpoA. The CpoA gene is part of an operon including another putative glycosyltransferase gene
spr0982, both of which being homologous to glycolipid synthases present in other Gram-positive bacteria.
Results: We now show that the cpoA mutants as well as a cpoA deletion mutant are defective in the synthesis of
galactosyl-glucosyl-diacylglycerol (GalGlcDAG) in vivo consistent with the in vitro function of CpoA as α-GalGlcDAG
synthase as shown previously. In addition, the proportion of phosphatidylglycerol increased relative to
cardiolipin in cpoA mutants. Moreover, cpoA mutants are more susceptible to acidic stress, have an increased
requirement for Mg2+ at low pH, reveal a higher resistance to lysis inducing conditions and are hypersensitive
to bacitracin.
Conclusions: The data show that deficiency of the major glycolipid GalGlcDAG causes a pleitotropic phenotype of
cpoA mutant cells consistent with severe membrane alterations. We suggest that the cpoA mutations selected with
piperacillin are directed against the lytic response induced by the beta-lactam antibiotic.
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Development of resistance to beta-lactam antibiotics in
Streptococcus pneumoniae involves alterations in the target
proteins, the penicillin-binding proteins (PBPs) which result
in decreased affinity to beta-lactams. In order to identify
individual mutations in S. pneumoniae that are related to
the resistance phenotype, a series of independent mutant
families has been selected in the laboratory using stepwise
increasing concentrations of antibiotics [1]. Two beta-
lactams were chosen for selection: piperacillin, which
induces rapid lysis in the bacteria, and cefotaxime which
does not interact with PBP2b and leads to a tolerant
response [2]. Point mutations in pbp2b from piperacillin-
resistant mutants and in pbp2x from cefotaxime resistant
mutants have been described [3-5]. Surprisingly, a decrease* Correspondence: hakenb@rhrk.uni-kl.de
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stated.in antibiotic susceptibility in some mutants correlated with
a mutation in non-PBP genes [6]. In two piperacillin-
resistant mutants, P106 and P104, obtained independently
after the first selection step before the introduction of PBP
mutations, the putative glycosyltransferase (GT) gene cpoA
was affected [7]. Decreased susceptibility for piperacillin
of the cpoA mutants was accompanied by a pleiotropic
phenotype such as a defect in genetic competence and
reduced amount of PBP1a. This indicated a novel mech-
anism directed against the activity of lytic β-lactams in S.
pneumoniae distinct from target-mediated resistance.
The CpoA gene spr0981 and the adjacent gene spr0982
encode putative GTs which belong to the GTB-type super-
family (GT1-YqgM-like family). Members of this GT family
are anchored in the membrane cytoplasmic interface by
hydrophobic and charge interactions [8,9] and transfer a
sugar moiety to an acceptor molecule located in the inner
leaflet of the membrane. Therefore, it had been proposed
that CpoA perfoms a similar function in S. pneumoniae [7].
Meanwhile, in vitro studies revealed that both proteins areLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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as α-monoglucosyl-diacylglycerol (GlcDAG) synthase and
CpoA as a α-galactosyl-glucosyl-diacylgylcerol (GalGlc-
DAG) synthase [9,10]. These two glycolipids occur at a
ratio of approximately 1:2.5 in the S. pneumoniae mem-
brane [11], in addition to phosphatidyl glycerol and cardi-
olipin which constitute the major phospholipids [12].
By consecutively synthesizing one nonbilayer-prone
(mono-glucosyl-DAG) and one bilayer-forming glycolipid
(di-glycosyl-DAG), the function of the GTs is crucial for the
bilayer spontaneous curvature which affects the physical
properties of the cytoplasmic membrane [13]. An example
is the mycoplasma Acholeplasma laidlawii, where bilayer
curvature is extensively regulated by two closely related
GTs consecutively synthesizing monoglucosyl-DAG and
diglucosyl-DAG [9,13], enzymes that are homologous to
S. pneumoniae Spr0982 and CpoA. Thus it is most likely
that CpoA and Spr0982 play a critical role in S. pneumo-
niae related to membrane associated functions in agree-
ment with the pleiotropic phenotype of the CpoA mutants
mentioned above. GlcDAG is the proposed lipid anchor of
the essential choline-containing lipoteichoic acid (LTA) of
S. pneumoniae [14]. In fact, spr0982 has been listed among
essential genes of this organism [15].
In the present report, a cpoA deletion mutant was
constructed and compared to the CpoA mutants P106
and P104; moreover, the cpoA operon was investigated
by mutational analysis. The aim of this study was to
examine the function of CpoA in vivo, and to further
our understanding on the physiological consequences
of cpoA mutations.
Results
The CpoA gene is part of an operon with five
downstream genes
P104 and P106 are spontaneous piperacillin-resistant
laboratory mutants isolated independently after one selec-
tion step from the laboratory strain S. pneumoniae R6 [4,7].
Both mutants contain a mutation affecting CpoA: in P104,
a transversion within cpoA GTA to GGA led to a Gly12Val
exchange in the predicted protein product, whereas in
P106, one adenine nucleotide was deleted 15 base pairs
(bp) upstream of the proposed cpoA start codon (ATG2
in Figure 1) [7]. Although ATG2 is not preceded by a
classical Shine Dalgarno sequence, this deletion was
suspected to affect the efficiency of ribosome binding to
the cpoA transcript [7]. However, the possibility remained
that translation actually starts at an alternative start codon
(ATG1 in Figure 1) 27 bp upstream of ATG2 which is
preceded by a perfect −10 region. In this case, the deletion
in P106 would lead to a frameshift in the 5th codon and
thus to the production of a nonsense peptide.
To first clarify this issue, the expression signals of cpoA
were mapped. The 5' end of cpoA mRNA was determinedby RACE, and shown to be located 27 bp upstream of
ATG2 (Figure 1B). Since this is exactly the position of the
alternative start codon ATG1, translation initiation at ATG1
would imply that the cpoA transcript is leaderless [16]. In
order to see whether ATG1 is indeed functional or whether
ATG2 is required for translation, three plasmids were
constructed in which the inferred promoter PcpoA together
with either both, ATG1 and ATG2 (PcpoA-ATG12), ATG1
plus a mutated ATG2 (PcpoA-ATG1ATA2), or ATG1 only
(PcpoA-ATG1), was translationally fused with the lacZ
reporter gene. After single-copy integration of the resulting
reporter constructs at the bgaA locus of R6, the expression
of lacZ was determined in two transformants in up to three
experiments. Beta-galactosidase activity was similar in
R6PcpoA-ATG1ATG2 and R6PcpoA-ATG1ATA2 (190–330
Miller Units), and slightly lower in R6PcpoA-ATG1 contain-
ing a shorter region upstream of lacZ (140–150 Miller
Units), clearly documenting that ATG1 is the translation
initiation site of cpoA and that the cpoA transcript is
indeed leaderless. In this case, P106 contains a deletion
within the structural gene resulting in a frameshift within
the 5th codon consistent with the failure to detect CpoA
in P106 with a specific anti-CpoA antiserum [7], and the
mutation in P104 is Gly21Val.
Comparison with the genetic organization of cpoA and
upstream regions of the closely related species S. mitis
B6 and S. oralis Uo5 of known genome sequence [17,18]
revealed an almost perfect conservation of cpoA including
the −10 region in these species (Figure 1B).
The arrangement of genes and expression signals pre-
dicted in the downstream region of PcpoA suggested a
polycistronic mRNA of approximately 4.4 kb covering
the cpoA-spr0985 region. This was confirmed by RT-PCR
experiments in which six overlapping products were
obtained from this region, the largest of which extended
from cpoA to spr0984 (Figure 1). Attempts to detect a
contiguous transcript of the entire cpoA-spr0985 region,
either by RT-PCR or by Northern blot analysis, however,
were not successful, probably due to instability of the
transcript.
The operon structure of the cpoA-spr0985 region and
bioinformatic analyses indicated that the gene products
might be functionally related and involved in membrane-
associated functions. The GT-activities of CpoA and
Spr0982 have been linked to glycolipid biosynthesis by
in vitro experiments [9,10], Spr0983 [58 amino acids 7
(aa)] belongs to the PspC superfamily of putative stress-
responsive transcriptional regulators, and Obg (436 aa)
belongs to the Obg subfamily of GTP-binding proteins
involved in stress response and processes related to cell
division [for review, see [19]]. Possible functions of the
two small peptides Spr0983.1 (44 aa) which has not
been annotated in the R6 genome and Spr0985 (52 aa)
[20] cannot be deduced from the amino acid sequences.
B1 2 3 4 5 kb
spr0980 spr0981 (cpoA) spr0982 spr0983 obg spr0985 tnp
PcpoA T2T1
spr0983.1
ATG1 ATG2
A
Figure 1 Genes, transcription and deletions in the cpoA-spr0985 region of S. pneumoniae R6. (A) Wide horizontal arrows indicate genes
apparently co-transcribed with cpoA (black), and flanking genes (white). spr0983.1 has not been annotated in the R6 genome [20], but its presence
has been predicted from other S. pneumoniae genomes such as TIGR4 [56]. The positions and extend of in-frame deletions are shown as white
boxes below the respective genes. Lines above the genetic map represent DNA products obtained by RT-PCR with total RNA and gene-specific
primers. The positions of the promoter PcpoA and of putative ρ-independent terminators (T1 [ΔG = −10.4 kcal/mol], T2 [ΔG = −10.1 kcal/mol]) are
given by angled and vertical arrows, respectively. (B) The nucleotide sequence upstream of S. pneumoniae R6 cpoA and putative 3'-coding
sequences is shown together with the predicted peptide sequence (Sp). The −10 element of PcpoA is underlined, and the transcription start site
(+1) is indicated with an angled arrow. The position of an adenine nucleotide, deleted in the mutant strain P106 [7] is marked with *Δ. Two
potential start codons of the cpoA gene (ATG1, ATG2; see text for detail) are underlined. The respective cpoA sequences of S. mitis B6 (Sm) and
S. oralis Uo5 (So) are shown below.
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To assess the importance of these gene products, we aimed
to construct deletions in each gene. A previous attempt
to delete cpoA by insertion-duplication mutagenesis using
a non-replicative plasmid vector had been unsuccessful
[7]. This suggested that either cpoA is essential, or that
insertion of the vector had affected the expression of the
downstream gene spr0982 which has been listed among
essential genes of S. pneumoniae [15]. To avoid such polar
effects, a different deletion strategy was applied which was
based on the construction of in-frame deletions using the
Janus cassette (Figure 1). R6 mutants in which 108 central
codons of cpoA (specifying the GT domain) were replaced
with the Janus cassette were obtained with common effi-
ciencies (0.2%), demonstrating that cpoA is a non-essential
gene. Deletions in spr0983 and spr0985 were also ob-
tained. However, the generation times of R6ΔcpoA and
R6Δspr0985 (with 46–48 min) were significantly longer
compared to R6 and R6Δspr0983 (38 min), suggesting that
CpoA and Spr0985 are involved in important functions. In
contrast, transformants carrying deletions in spr0982 and
obg occurred only at 1,000- and respectively 10,000-foldreduced frequencies. This is in agreement with an essential
function of the spr0982 product as reported previously [15],
and strongly suggested that also obg is indispensable. The
rare recovery of transformants carrying deletions in
these genes probably was the result of co-selection of
compensatory mutations at unknown secondary sites.
Mutants in cpoA are defective in synthesis of diglycosyl-DAG
To verify the CpoA function in vivo, the membrane
lipids of cpoA mutant strains and the parent S. pneumo-
niae R6 were isolated and glycolipids specifically stained
after separation by thin layer chromatograpy (Figure 2).
S. pneumoniae contains the two glycolipids GlcDAG and
GalGlcDAG. Two spots were detected in the R6 strain
that could be assigned to the pneumococcal glycolipids
according to the glycolipid standards: the major one
representing a diglycosyl-DAG (most likely GalGlcDAG
close to the position of the GalGalDAG standard), and
a second spot at the position of monoglycosyl-DAG
(Figure 2). This is in agreement with a ratio of GlcDAG
to GalGlcDAG to be approximately 1:2.5 [11]. In contrast,
the only glycolipid in all cpoA mutants corresponded to
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Figure 2 Glycolipids in ΔcpoA and piperacillin resistant laboratory mutants containing cpoA mutations. Lipids extracted from strain R6
and from cpoA mutants, P104, P106, and R6ΔcpoA as indicated above the lanes were separated by thin layer chromatography (chloroform/
methanol/acetic acid = 80:15:8). GalGalDAG (S1) and GlcDAG (S2) were used as a standards. Spots were assigned to the two major glycolipids of
S. pneumoniae diglycosyl DAG (GalGlcDAG) and monoglycosyl DAG (GlcDAG).
R6 P104 P106R6ΔcpoA
CL
PG
1.D
2.D
Figure 3 Phospholipids in cpoA mutants. Lipids were extracted
and separated by two dimensional TLC. 1.D and 2.D: first and second
dimension (first dimension: CHCl3/MeOH/H20 = 65:25:4; second
dimension: CHCl3/AcOH/MeOH/H20 = 80:14:10:3). Phospholipids were
visualized by spraying with Molybdenum Blue spray reagent. PG:
phosphatidylgylcerol; CL: cardiolipin. Spots were assigned according to
the phosphatidylglycerol standard (see Additional file 1: Figure S1) and
Fischer [42].
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confirms that CpoA is required for the synthesis of the
diglycosyl-DAG in S. pneumoniae in agreement with
the in vitro GalGlcDAG-synthase activity of CpoA, and
documents that both mutants, P104 and P106, do not
contain a functional CpoA.
Phospholipids in cpoA mutants
The glycolipid content affects physical properties of the
cytoplasmic membrane. Since the exclusive production of
the monolayer-forming glycolipid GlcDAG which forms
non-bilayer structures strongly affects the membrane
curvature [9,13], we investigated whether this has some im-
pact on the phospholipid content as well. S. pneumoniae
contains the two phospholipids cardiolipin, a non-bilayer
prone lipid, and phosphatidylglycerol. Lipids were separated
by two-dimensional thin layer chromatography, and ex-
periments were performed with at least two independently
grown cultures. All cpoA mutants (R6ΔcpoA, P104 and
P106) showed a significant increase in the ratio of phos-
phatidylglycerol: cardiolipin (Figure 3), suggesting that the
cells are able to regulate the overall content of bilayer
versus non-bilayer forming lipids. It should be noted
that phosphadidylglycerol is more strongly stained com-
pared to cardiolipin by the procedure used here (Additional
file 1: Figure S1).
Pleiotropic phenotype of cpoA mutants
The severe changes in membrane lipids in cpoA mutants
is consistent with their pleiotropic phenotype described
before [1,7] which included a reduced generation time in
liquid medium, decreased susceptibility to beta-lactams,
defects in transformability, and a lower amount of PBP1awith less than 20% compared to the parental strain while
the pbp1a transcript was unaffected; alterations in other
PBPs were not detected. We first verified these properties
for the R6ΔcpoA mutant: the MIC of piperacillin increased
from 0.015 μg/ml (R6) to 0.045 μg/ml, the competence for
genetic transformation was approximately 20-fold lower
and shifted to the early exponential phase compared to R6,
and the amount of PBP1a was decreased (not shown).
These phenotypes are reminiscent of those displayed
by P104/P106 but were more pronounced in R6ΔcpoA,
probably a result of the rpsL allele.
Several other tests were then performed in order to
see whether the altered glycolipid composition affects also
cell envelope related properties in general. These included
growth at low pH, the requirement for Mg2+, stationary
phase autolysis and lysis induced by Triton X100. In all
experiments, cpoA mutants showed a clear phenotype
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at pH 6 (Figure 4). At pH 6, cpoA mutants showed an
increased requirement for Mg2+ (Figure 5). The station-
ary phase lysis was slightly delayed in all cpoA mutants
(Figure 4). Moreover, lysis induced by low concentrations
of Triton X100 proceeded significantly more slowly in all
cpoA mutants (Figure 6).
Susceptibility to non-beta lactam cell wall antibiotics was
also tested. Almost no effect was seen with vancomycin
(MIC = 0.35 - 0.45 μg/ml) or cycloserine (MIC = 65–75 μg/
ml), but the MIC value for bacitracin dropped from 7.5 μg/
ml in the R6 strain to 0.75 - 1 μg/ml in all cpoA mutants.
Transcription profile of cpoA mutants
The pleiotropic effect of cpoA mutants on many membrane-
associated functions was consistent with the relation of
CpoA activity to glycolipid biosynthesis. In order to esti-
mate the consequences of the altered glycolipid compos-
ition in cpoA mutants, their transcription pattern was
determined in comparison to the R6 parent strain using
an S. pneumoniae R6 specific oligonucleotide microarray
[21]. Cells were grown under non-competent conditions
at pH 6.8 in order to avoid the detection of the complex
com regulon. Only four gene clusters and one single gene
were affected in all three mutants. This included the
approximately 3-fold downregulation of a PTS system
(spr0276 - spr0282) and an ABC transporter (spr1545 -
spr1549), and the 5-7-fold upregulation of two ABC trans-
porters (vex, spr0524 - spr0526; spr1558 - spr1560) and
spr0307 clpL (approximately 4-fold; Additional file 2:
Table S3). No effect on PBP genes or genes involved in
lipid biosynthesis was apparent.A
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Figure 4 Growth of cpoA mutants in low pH medium. Strains were gro
[NU]. The growth was examined at pH 8 (circles) and pH 6 (squares). A: R6;Discussion
Glycolipids in cpoA mutants
The two piperacillin-resistant S. pneumoniae laboratory
mutants P104 and P106, both containing point mutations
affecting CpoA production, do not produce detectable
amounts of GalGlcDAG, the main glycolipid of this organ-
ism. This clearly shows that the glycosysltransferase CpoA
of S. pneumoniae is essential for the synthesis of the major
glycolipid GalGlcDAG in vivo, and this could be confirmed
by cpoA deletion mutants. The data are in agreement with
previous in vitro studies using extracts of E. coli overpro-
ducing CpoA [9].
Apparently, the amino acid change in CpoAP104 Gly21Val
also results in a non-functional protein. Since the mutated
protein is still associated with the membrane when cell frac-
tions were probed with anti-CpoA antiserum (Additional
file 1: Figure S2), it is possible that the Gly21Val mutation
affects protein folding, or its enzymatic function directly
or indirectly. In this context it is interesting to note that a
missense mutation in cpoA has been identified recently in
laboratory mutants selected with cefotaxime [22]. The
mutation D186Y [listed in the paper as D213Y due to
wrong annoation of cpoA in the R6 genome [20]] is located
within the conserved region of this type of glycosyltransfer-
ases, and it would be interesting to study the glycolipid con-
tent and phenotype in this mutant. So far, mutations in
cpoA have not been detected in clinical isolates of S. pneu-
moniae. This might not be surprising since glycolipids are
involved in critical cellular functions. On the other hand,
the study of laboratory mutants resistant to beta-lactam
antibiotics provides a valuable tool to unravel physiological
processes related to cell envelope biosynthetic processes.B
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Figure 5 Mg2+ requirement of cpoA mutations. Strains were grown in C-medium pH 6, and culture density was monitored by nephelometry
[NU]. The medium contained either 0.195 mg/ml MgCl2 final concentration (filled circles) or 0.39 mg/ml MgCl2 (squares). A: R6; B: P104; C: P106;
D: R6ΔcpoA.
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Glycolipids are common in Gram-positive bacteria, and
their distribution across the cytoplasmic membrane rep-
resents a critical parameter affecting bilayer curvature
of the membrane and lipid surface charge densities, thus
also membrane-associated functions [23]. Glycolipids in
the cell wall-less mycoplasma Acholeplasma laidlawii are
asymmetrically distributed and mainly external [24]. Clear
asymmetry of lipids has also been documented for special
membrane systems, such as the purple membrane of the0.5
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D
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0.6
Figure 6 Triton induced lysis. Cells were grown to OD600 in C-medium. A
circles; R6ΔcpoA: open circles; P106: open triangles; P104: open squares.archaebacterium Halobacterium halobium where glycolipids
were found exclusively in the outer leaflet [25,26], and for
the outer membrane of Gram-negative bacteria [27]. It is
likely that also in S. pneumoniae the two glycolipids are
arranged asymmetrically in the membrane and probably
predominantly located in the outer leaflet.
Besides glycolipids, membrane proteins can also contrib-
ute substantially to the morphology and curvature of
membranes [28]. The two GTs of A. laidlawii, homologues
of Spr0982 and CpoA, have recently been shown to induce40 50 60 190
e [min]
t OD600 = 0.5, Triton (0.01% final concentration) was added. R6: filled
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These enzymes are monotopic, i.e. anchored in the mem-
brane cytoplasmic interface by hydrophobic and charge
interactions in a SecYEG-independent manner [8,9]. The
data of Wikström et al. [29] strongly suggest that the GTs
themselves are capable of inducing vesiculation, i.e. con-
vex bending of the membrane. This implies some possible
consequences when CpoA is absent, i.e. in P106 and in
R6ΔcpoA, in that elimination of CpoA itself could affect
the curvature of the membrane.
Phenotypes of cpoA mutants
Failure to synthesize GalGlcDAG, the bilayerforming
di-glycosyl-glycolipid, must affect the physical properties
of the cytoplasmic membrane considerably, consistent with
the pleiotropic phenotype associated with cpoA mutants.
Introduction of the cpoA point mutations present in P104
and P106 into the parental R6 strain conferred the same
phenotypes, strongly suggesting that no other mutations
besides cpoA are present in P104 and P106 (not shown).
This included higher susceptibility to acidic stress and
increased requirement for Mg2+ at low pH, as well as
reduced lysis rate under lysis inducing conditions. More-
over, an altered proportion of the two pneumococcal phos-
pholipids was observed in the cpoA mutants. Whereas
cardiolipin is the major phospholipid in the parental R6
strain, all cpoA mutants contained a considerable higher
amount of phosphatidylglycerol relative to cardiolipin as
shown in Figure 3. Interestingly, mutations in the gene
encoding the cardiolipin synthase have been identified in
cefotaxime resistant laboratory mutants but have not been
investigated further [22]. Since GlcDAG, the only glyco-
lipid in cpoAmutants, is non-bilayer prone and cardiolipin
as well, apparently the cells are capable to regulate the
amounts of lipids to ensure sufficient bilayer structure of
the cytoplasmic membrane. Cross-regulation in membrane
lipid pathways has already been suggested in B. subtilis
mutants defective in the cardiolipin synthase gene [30].
MIC values of vancomycin or cycloserine inhibiting late
and early stages of peptidogylcan synthesis were not
affected in cpoA mutants, an indication that the cell wall
biochemistry is not affected.
Interestingly, cpoA mutants were ten-fold more sus-
ceptible to bacitracin, which targets the lipid molecule
bactoprenol. The cpoA mutants expressed an altered
transcription profile compared to that of the R6 strain,
mainly by genes encoding membrane proteins such as
PTS systems or ABC transporters that represent minor
components of the bacterial cell. On the other hand,
we could not detect significant changes of the protein
profile of cytoplasmic or membrane proteins on SDS-
polyacrylamide gels, i.e. no major protein components
were affected in terms of quantity (not shown). It is
conceivable that the transcriptional changes might be anindirect effect of the altered membrane composition. We
recently reported that a higher susceptibility to bacitracin
was also noted in S. pneumoniae containing a mutated
ABC transporter [31]. It is possible that the altered lipid
composition of the cpoA mutants indirectly affects the
ABC transporter function and thus bacitracin MIC.
Glycolipids as anchor molecules in Gram-positive bacteria
Glycolipids represent the membrane anchor of important
membrane-bound cell wall polymers in Gram-positive bac-
teria. They function as the lipid anchor for LTA and also
for another class of membrane-associated cell wall glycopo-
lymers, lipoglycans, which seem to replace LTA in the high
GC division of Gram-positive bacteria [32,33]. Listeria
contain the same glycolipids as S. pneumoniae, whereas
GlcDAG and GlcGlcDAG represent the major glycolipids
in Bacillus, Staphylococcus and Enterococcus. However,
these species differ in their biosynthetic enzymes. In
Bacillus and Staphylococcus, both glycolipids are synthe-
sized by one single GT YpfP [34-36], whereas two putative
GTs are involved in glycolipid biosynthesis in Listeria,
Streptococcus and Enterococcus [9,10,37,38]. In this context
it is remarkable that the structure of the cpoA operon
which includes obg and several putative small peptide
encoding genes is only maintained within Streptococcus
spp., and that other Gram-positive bacteria contain cpoA
(plus spr0982 in case of Listeria and Enterococcus) and obg
homologues at distinct positions in the genome. The
reason for this is not clear. Several studies revealed that
Obg proteins play a role in many important processes,
including DNA replication, chromosome segregation,
and regulation of stress responses, but their actual function
remains unknown [for review, see [19]].
Most of the species mentioned above contain a polygly-
cerophosphate LTA backbone which is anchored to the
di-glycosyl-DAG lipid. Thus, interference of the biosyn-
thesis of this glycolipid severely affects LTA and accordingly
cell wall integrity as was shown for mutants in the S. aureus
GT YpfP [34,35], the (1 → 2)GTs LafA in Listeria, IagA in
group B streptococci, and E. faecalis BgsA [37-39]. Deletion
mutants of S. aureus ypfP produced LTA which was prob-
ably attached directly to DAG [34,35]. In the GC-rich
organism M. luteus, dimannosyl-DAG is the lipid anchor of
the essential lipomannan cell wall polymer [40]. Therefore,
temperature sensitive mutants defective in lipomannan
assembly were isolated of M. luteus, and one of them
(mms1) contained a reduced amount of dimannosyl-DAG
whereas the amount of monomannosyl-DAG was increased
[41]. The corresponding M. luteus gene encoding a putative
GT is unknown; according to BLAST analysis, the GT
encoded by mlut_06690 is a likely CpoA homologue.
In contrast to these organisms, the LTA of S. pneumoniae
is unique in that it includes choline and unusual sugar
moieties in its repeating unit which is identical to that of
Table 1 S. pneumoniae strains and plasmids
Strains Relevant properties Source or
reference
R6 Unencapsulated laboratory
strain
[57]
P106 R6 derivative; piperacillin
resisant; cpoA
[1,7]
P104 R6 derivative; piperacillin
resisant; cpoA
[1,7]
AmiA9 rpsLA167C, Str
R [51]
R6s R6 StrR, (AmiA9) This work
R6ΔcpoA R6s, rpsL, ΔcpoA, StrR This work
Plasmids
pTP2 Selection in S. pneumoniae:
tetracycline 3 μg/ml
Selection in E.coli: ampicillin
100 μg/ml
GeneBank
Nr. EF061140
pTP2PcpoA-ATG21 This work
pTP2PcpoA-ATG1a This work
pTP2PcpoA-ATG1a This work
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gests strongly that the closely related species S. oralis and
S. mitis contain similar TA molecules [43]. Moreover,
special choline-binding proteins are associated with the
TA molecules, some of which are involved in crucial
functions including cell separation [for review, see [44]],
probably one of the reasons why LTA and its biosynthetic
enzymes are essential in S. pneumoniae.
Early studies predicted the LTA lipid anchor to be Glc
(β1→ 3)AATGal(β1→ 3)Glc(α1→ 3)DAG where AATGal
is 2-acetamino-4-amino-2,4,6-trideoxy-D-galactose [42], but
recent data provide evidence that GlcDAG is the more
likely anchor molecule [14], i.e. the product of the reaction
catalyzed by the GT Spr0982 [10]. Failure to isolate
deletions mutants in spr0982 are in agreement with the
essential nature of the S. pneumoniae LTA. No effect
on choline incorporation into the cell wall was noted
in the piperacillin resistant mutants [1], suggesting that
teichoic acids seem to be present in similar amounts in
mutant cells compared to R6 and that its biosynthesis
is not affected by cpoA mutations. The estimated number
of molecules for LTA and GlcDAG is in the same range
of magnitude. LTA constitutes up to 20% of the lipid
molecules in the outer leaflet of the cytoplasmic membrane
in S. pneumoniae [32], and glycolipids represent 34% of
the lipids in S. pneumoniae [12] with almost one third
being GlcDAG [11].
Conclusions
Here we have shown that CpoA acts as the glycosyltrans-
ferase in vivo responsible for the biosynthesis of the major
glycolipid GalGlcDAG in S. pneumoniae. The altered lipid
composition of cpoA mutants - GlcDAG as the only
glycolipid, and a higher proportion of phosphatidylglycerol
relative to cardiolipin - affects many membrane related
functions and thus results in a pleiotropic phenotype.
The question remains why the selection of piperacillin-
resistant laboratory mutants P104 and P106 resulted in
the isolation of cpoA mutations. Since cpoA was not
affected in another six mutant families selected with
cefotaxime, a beta-lactam that induces a tolerant response
[2], the cpoA mutations are probably related to the highly
lytic action of piperacillin. Changes of the physical proper-
ties of the membrane by alteration of the lipid composition
might be an effective measure to counteract the lytic re-
sponse induced by beta-lactams and other agents as well.
Methods
Bacterial strains, plasmids, oligonucleotides, growth
conditions, and transformation
Streptococcus strains and plasmids used in this work are
listed in Table 1. PCR primers were synthesized at Operon
Biotechnologies and are listed in Additional file 2: Table S1.
Primers used for sequencing and confirming the correctintegration of DNA sections delivered to the S. pneumoniae
genome and nested primers are not listed. S. pneumoniae
was grown in C-medium [45] supplemented with 0.2%
yeast extract or in Todd Hewitt Broth [THB] (Becton and
Dickinson) at 37°C without aeration. For growth on solid
surface, D-agar [46] supplemented with 3% defibrinated
sheep blood (Oxoid) was used. Growth of S. pneumoniae in
liquid cultures was monitored by nephelometry (nephelo
units [NU]), and doubling time (generation time) estimated
from at least three independent experiments. To determine
minimal inhibitory concentractions (MICs) of piperacillin,
cultures of S. pneumoniae, grown in C-medium to a density
of 30 NU, were diluted 1000-fold in 0.9% NaCl, and ali-
quots (30 μl) of the dilutions were spotted on D-agar
plates containing piperacillin at concentrations of 0.01 to
0.3 μg/ml using 0.005 μg/ml intervals. MIC values for baci-
tracin, vancomycin and cycloserine were also determined
on D-agar plates using appropriate dilutions of the anti-
biotic. Antibiotic resistance genes used for chromosomal
integrations in S. pneumoniae were selected with 2 μg/ml
erythromycin (Erm, ermAB), 200 μg/ml kanamycin (Kan,
aphIII), 200 μg/ml streptomycin (Str, rpsL), and 3 μg/ml
tetracyclin (Tet, tetM), respectively. Transformation of S.
pneumoniae was performed using naturally competent
cells as described previously [47]. Transformation efficiency
was calculated as the percentage of colonies obtained on
the selective medium compared to the colony number on
control plates without antibiotic.
DNA manipulations
Isolation of plasmid DNA and routine DNA manipulations
were carried out by standard methods [48]. PCR products
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gestions were purified using the JETquick spin column
technique kit. Restriction enzymes and T4 DNA ligase were
purchased from Roche Applied Science or New England
Biolabs and used according to the manufacturer’s instruc-
tions. PCRs were performed using either Goldstar Red
Taq polymerase (Eurogentec) or iProof High-Fidelity DNA
polymerase (Bio-Rad) according to the manufacturer’s
instructions. Nucleotide sequencing was performed using
the ABI Prism BigDye Terminator Ready Reaction cycle
sequencing kit, version 3.1 (Perkin Elmer-ABI). Nucleotide
sequences were analyzed by using the CloneManager and
Phred/Phrap/Consed software.
Identification of transcription start site
The start point of cpoA transcription was determined by
rapid amplification of cDNA ends (5' RACE) as described
previously [49] using RNA of S. pneumoniae R6 isolated
at a culture density of 40 NU. The primer cpoARACE2
was used for reverse transcription of RNA ligated to the
RNA adapter, and the nested primer and cpoARACE1 was
used for amplification of cDNA (for primers, see Additional
file 2: Table S1 and S2).
Construction of delivery cassettes, plasmids and mutants
To identify the initiation site of cpoA translation, fusions
of two DNA fragments with the lacZ reporter gene were
constructed. They contained PcpoA (i) together either with
two potential start codons (ATG1 and ATG2 in Figure 1B),
(ii) with a mutation in ATG2 (ATA), or (iii) with ATG1
only. The three fragments were amplified from chromo-
somal DNA of S. pneumoniae R6 by using the primer pairs
PcpoA_Eco_f/PcpoA_r2, PcpoA_Eco_f/PcpoABam_r1a and
PcpoA_Eco_f/PcpoABam_r1b, cleaved with EcoRI and
BamHI, and ligated with the EcoRI/BamHI-digested
translation probe vector pTP2. The desired plasmids,
pTP2PcpoA-ATG21, pTP2PcpoA-ATG1a and pTP2PcpoA-
ATG1b were isolated after transformation of E. coli DH5α
and subsequently used to transform S. pneumoniae R6;
alternatively plasmids were directly transformed into S.
pneumoniae R6. DNA from TetR transformants was PCR-
amplified and sequenced to confirm the presence of the
lacZ fusions in the resulting strains R6-PcpoA-ATG21,
R6-PcpoA-ATG1a and R6-PcpoA-ATG1b.
In-frame deletions in cpoA, spr0982, spr0983, obg, or
spr0985 were constructed via a two-step process in which
the central part of the respective gene(s) was first replaced
with the Janus cassette [50] that confers a KanR StrS
phenotype in a StrR background. In the second step, the
Janus cassette was deleted, thus restoring the original StrR
phenotype. The constituents of ‘replacement fragments’
and ‘deletion fragments’ used in the first and second steps
of each deletion were amplified from chromosomal DNA
of S. pneumoniae R6 by using the primer pairs listed inAdditional file 2: Table S2. To generate a ‘replacement
fragment’, two PCR products of 0.7 to 1 kb (‘upstream’ and
‘downstream fragment’) flanking the desired deletion were
joined with the two ends of the Janus cassette either by
the use of appropriate restriction sites added to the ends
of the respective primers or by overlap extension PCR
with nested primers. The ‘replacement fragment’ was used
to transform a StrR derivative of S. pneumoniae R6 (R6s)
obtained by transformation of R6 with chromosomal
DNA carrying the AmiA9 resistance marker [51]. In the
resulting KanR StrS transformants, the correct position of
the Janus cassette was confirmed by DNA extraction and
PCR with appropriate primers. To generate a ‘deletion
fragment’ (containing the desired deletion), the respective
‘upstream’ and ‘downstream fragments’ were directly joined
with each other either by the use of appropriate restriction
sites added to the primers or by overlap extension PCR
with nested primers. The ‘deletion fragment’ was used to
transform a derivative of R6s carrying the Janus cassette at
the site of the desired deletion. DNA from transformants
displaying a KanS StrR phenotype was PCR-amplified and
sequenced to confirm the presence of the deletion in the
resulting mutant.
Determination of β-galactosidase activity
Preparation of cell extracts from cultures of S. pneumoniae,
grown to a density of OD600 = 0.8 in C-medium, and
determination of specific β-galactosidase activities were
performed as described [52].
Lipid extraction and analysis
Lipids were extracted from S. pneumoniae essentially as
described [53]. Briefly, cells harvested by centrifugation
of liquid cultures grown to a density of about 70 NU
were resuspended in 0.8 ml H2O per gram wet weight
and subsequently mixed with 3 ml of chloroform/
methanol (1:2) per gram wet weight. After gentle agitation
for 2 h at 4°C, chloroform (1 volume) and H2O (1 volume)
were added and mixed. The samples were centrifuged at
4,000 × g and 4°C for 5 min, the organic phases were
recovered, mixed with 1 volume of H2O equilibrated with
chloroform/methanol (1:2), and centrifuged as before.
Recovered organic phases were completely evaporated,
and the remainders were dissolved in 50 to 100 μl of
chloroform/methanol (80:15). Glycolipids were separated
by one-dimensional thin layer chromatography in chloro-
form/methanol/acetic acid (80:15:8) on silica gel G plates
(0.025 mm; Merck). For visualization the plates were
sprayed with 1-naphthol (3.2% w/v in methanol/H2SO4/
H2O = 25:3:2) and heated at 110°C for 10 min. GalGal-
DAG (Sigma) and GlcDAG were used as standards.
Phospholipids were separated on two-dimensional thin
layer chromatography (first dimension: CHCl3/MeOH/
H2O = 65:25:4; second dimension: CHCl3/AcOH/MeOH/
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oxide in 4.2 M sulfuric acid (Molybdenum Blue spray
reagent, Sigma-Aldrich). Spots were assigned according to
the reference lipid phosphatidylglycerol (Sigma) and the
pattern described elsewhere for phospholipids [42].Immunological detection of CpoA
S. pneumoniae cells were grown to mid-exponential growth
phase (80 NU), harvested by centrifugation (9,000 rpm,
15 min, 4°C, Beckman centrifuge J2-21), and washed once
with 20 mM sodium phosphate buffer pH 7.2. Pellets were
resuspended in 180 μl sodium phosphate buffer and mixed
with 500 mg glass beads per 100 mg wet weight, followed
by disruption in a cell mill (Vitrogen-Zellmühle Typ VI-4,
Edmund Bühler GmbH) for 20 min. All further steps were
carried out on ice. Glass beads were removed by centrifuga-
tion for 6 min (14,000 rpm, 4°C, Hermle Z513K centrifuge).
Membranes were separated from cytoplasmic proteins
by ultracentrifugation (Beckman centrifuge, TLA 100.4
rotor) for 2 h at 60,000 rpm and 4°C. Pellets were resus-
pended in half of the volume of the supernatant, and
fractions stored at −80°C. For SDS polyacrylamide gel
electrophoresis, 3 μl per fraction were used. Western
blotting was performed as described previously [54] and
CpoA was visualized using a 1:10,000 dilution of rabbit
antiserum raised against a purified CpoA-derivative as
described [7].Microarray-based transcriptome analysis
Extraction of total RNA from exponentially growing S.
pneumoniae cultures (40 NU), reverse transcription of
RNA into labeled cDNA, prehybridization, hybridization,
slide washing, scanning, and analysis of the data were
performed as described previously [55]. For each strain,
data sets from at least four hybridizations were used for
normalization and statistical analysis. Only data which
showed P values below 10-4 in a paired t test, and relative
changes in the transcript amount of greater than threefold
were considered further. The oligonucleotide microarray
covering genes and intergenic regions of S. pneumoniae
R6/TIGR4 has been described [21].Accession number
S. pneumoniae R6/TIGR4 oligonucleotide microarray:
ArrayDesign R6/TIGR4 ArrayExpres accession number
A-MEXP-1846.Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional files.Additional files
Additional file 1: Figure S1. Phospholipids in S. pneumoniae R6. Lipids
were extracted and separated by two dimensional TLC. 1.D and 2.D: first
and second dimension (first dimension: CHCl3/MeOH/H20 = 65:25:4;
second dimension: CHCl3/AcOH/MeOH/H20 = 80:14:10:3). Phospholipids
were visualized by spraying with Molybdenum Blue spray reagent. PG:
phosphatidylgylcerol; CL: cardiolipin. Standards: PG, 0.3 μMol; CL, 0.17 μmol.
Figure S2. Membrane association of CpoA. Membrane (m) and cytoplasmic
proteins (s) were separated by SDS-PAGE followed by immunostaining with
anti-CpoA antiserum (see Methods for detail). Closed arrows indicate the
position of CpoA in the membrane fractions of S. pneumoniae R6 and P104,
the open arrow shows the absence of CpoA in R6ΔcpoA. M: marker
proteins.
Additional file 2: Table S1. Primers. Table S2. PCR primer pairs used
for the construction of in-frame deletions 1. Table S3. Altered transcription
profiles in cpoA mutants.Abbreviations
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